Travere Therapeutics Inc (NASDAQ:TVTX)
| 21.89 BATS BZX Real-Time Price As of 12:52pm ET |  -0.51 / -2.28%Today’s Change | 12.75 Today|||52-Week Range 31.65 | -29.48% Year-to-Date |
Latest TVTX News | Press Releases
No recent news for Travere Therapeutics Inc.
Today’s Trading
| Previous close | 22.40 |
| Today’s open | 21.86 |
| Day’s range | 21.71 - 22.39 |
| Volume | 14,084 |
| Average volume (3 months) | 782,849 |
| Market cap | $1.5B |
Data as of 12:52pm ET, 05/25/2022
Growth & Valuation
| Earnings growth (last year) | +15.55% |
| Earnings growth (this year) | -25.02% |
| Earnings growth (next 5 years) | +137.00% |
| Revenue growth (last year) | +14.71% |
| P/E ratio | NM |
| Price/Sales | 8.16 |
| Price/Book | 5.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DVAXDynavax Technologies... | -0.02 | -0.18% |
| IBRXImmunitybio Inc | -0.17 | -4.49% |
| XNCRXencor Inc | -0.15 | -0.67% |
| SRRASierra Oncology Inc | +0.12 | +0.22% |
Data as of 12:54pm ET, 05/25/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | -$0.92 |
| Annual revenue (last year) | $227.5M |
| Annual profit (last year) | -$180.1M |
| Net profit margin | -79.16% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
